Bnp Paribas Arbitrage, Snc »

Eupraxia Pharmaceuticals shares owned by Bnp Paribas Arbitrage, Snc

Quarter-by-quarter ownership of Eupraxia Pharmaceuticals (EPRX) shares owned by Bnp Paribas Arbitrage, Snc from 13F filings

Historical chart of Bnp Paribas Arbitrage, Snc investment in Eupraxia Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Eupraxia Pharmaceuticals held by Bnp Paribas Arbitrage, Snc consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Eupraxia Pharmaceuticals by Bnp Paribas Arbitrage, Snc

Quarter filed Position value Share count Share price at filing
2026-03-31 $47k 6.4k 7.24

More positions owned by Bnp Paribas Arbitrage, Snc

NVIDIA Corp Equity (NVDA)
Microsoft Corp Equity (MSFT)
Amazon.com Equity (AMZN)
Apple Equity (AAPL)
State Street SPDR S&P Biotech ETF Fund (XBI)
Tesla Equity (TSLA)
Broadcom Equity (AVGO)
Alphabet Equity (GOOGL)
Alphabet Equity (GOOG)
JPMorgan Chase & Co Equity (JPM)
Meta Platforms Equity (META)
State Street SPDR S&P 500 ETF Trust Fund (SPY)
Micron Technology Equity (MU)
iShares Russell 2000 ETF Fund (IWM)
Oracle Corp Equity (ORCL)

View all positions for Bnp Paribas Arbitrage, Snc

Top funds holding Eupraxia Pharmaceuticals

Beutel, Goodman & Company
Vivo Capital
Balyasny Asset Management
Scotia Capital
Ikarian Capital
Dr. Jeffrey R. Jay, M.D.
Point72 Asset Management
UBS Group
Redmile Group
Rubric Capital Management
Squadron Capital Management
Ally Bridge Group
Ameriprise Financial
Woodline Partners
Seven Fleet Capital Management

View all funds holding Eupraxia Pharmaceuticals